Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

5,e]azepine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 9 USDMF, 1 EU WC, 1 NDC API, 2 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

27 FDF Dossiers, 16 FDA Orange Book, 2 Europe, 3 Australia, 2 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 75MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 SPI Pharma, 8 DKSH, 3 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 4 ACG Worldwide, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 1 DFE Pharma, 3 Gangwal Chemicals, 3 Ingredion Pharma Solutions, 1 Kerry, 3 Lonza Capsugel, 5 Microlex e.U, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 10 Roquette, 1 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Sigachi Industries, 2 Silverline Chemicals, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

22 Fillers, Diluents & Binders, 15 Lubricants & Glidants, 12 Disintegrants & Superdisintegrants, 9 Coating Systems & Additives, 8 Thickeners and Stabilizers, 8 Empty Capsules, 6 Direct Compression, 6 Taste Masking, 5 Granulation, 3 Controlled & Modified Release, 3 Chewable & Orodispersible Aids, 3 Coloring Agents, 3 Co-Processed Excipients, 3 Emulsifying Agents, 3 Film Formers & Plasticizers, 1 Surfactant & Foaming Agents, 1 API Stability Enhancers, 1 Topical

DIGITAL CONTENT

6 News #PharmaBuzz

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Regulatory FDF Prices

MARKET PLACE

2 APIs

2 APIs

REF. STANDARDS & IMPURITIES

1 Others

1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
04/06/2025	Lupin Ltd	India	M/s Lupin Ltd	WC-0201	Imipramine Pamoate USP	2022-09-30	2025-09-10	T-142, MIDC, Tarapur, Boisar, Palghar - 401506, Maharashtra, India

5,e]azepine

5,e]azepine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers

9 USDMF

1 EU WC

1 NDC API

2 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

27 FDF Dossiers

16 FDA Orange Book

2 Europe

3 Australia

2 South Africa

4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 75MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 SPI Pharma

8 DKSH

3 Faran Shimi Pharmaceutical

2 Gangwal Healthcare

4 ACG Worldwide

1 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 BASF

1 DFE Pharma

3 Gangwal Chemicals

3 Ingredion Pharma Solutions

1 Kerry

3 Lonza Capsugel

5 Microlex e.U

1 Pharmatrans-Sanaq

3 Pluviaendo

2 Prachin Chemical

1 Qualicaps

10 Roquette

1 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Sigachi Industries

2 Silverline Chemicals

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

22 Fillers, Diluents & Binders

15 Lubricants & Glidants

12 Disintegrants & Superdisintegrants

9 Coating Systems & Additives

8 Thickeners and Stabilizers

8 Empty Capsules

6 Direct Compression

6 Taste Masking

5 Granulation

3 Controlled & Modified Release

3 Chewable & Orodispersible Aids

3 Coloring Agents

3 Co-Processed Excipients

3 Emulsifying Agents

3 Film Formers & Plasticizers

1 Surfactant & Foaming Agents

1 API Stability Enhancers

1 Topical

DIGITAL CONTENT

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

2 Regulatory FDF Prices

MARKET PLACE

2 APIs

CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 150MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 75MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons